Enhancing manufacturing with process analytical technology (PAT) in 2025
Supported by:
17 April 2025
2:00pm
Shares
- Like
- Digg
- Del
- Tumblr
- VKontakte
- Buffer
- Love This
- Odnoklassniki
- Meneame
- Blogger
- Amazon
- Yahoo Mail
- Gmail
- AOL
- Newsvine
- HackerNews
- Evernote
- MySpace
- Mail.ru
- Viadeo
- Line
- Comments
- Yummly
- SMS
- Viber
- Telegram
- Subscribe
- Skype
- Facebook Messenger
- Kakao
- LiveJournal
- Yammer
- Edgar
- Fintel
- Mix
- Instapaper
- Copy Link
During this virtual panel, industry experts will explore the latest developments and biggest challenges in process analytical technology (PAT) today.
In the pharmaceutical industry, PAT can help enhance process understanding as well as product quality.
PAT tools utilising techniques such as spectroscopy and chromatography, Nuclear Magnetic Resonance (NMR), applied inline, online and at-line, are beneficial for monitoring and controlling critical parameters during manufacturing. For instance, PAT is valuable asset in QbD-based manufacturing.
Spectroscopic methods like near infrared (NIR), Raman and Fourier transform infrared (FTIR) spectroscopy offer advantages in pharmaceutical manufacturing, for example, as sample collection or manipulation is not necessary. NMR for example is crucial for determining molecular structures and identifying drug metabolites. Yet key challenges are still present despite major progress over the last ten years, preventing regular implementation of this technology.
Hear speakers share their own experience on best practice when incorporating PAT to aid pharmaceutical processes. The session will cover applications of the technology, innovative PAT tools, as well as addressing obstacles to its broader adoption in the pharmaceutical industry.
Key learning points:
- Find out how PAT is being applied in pharmaceutical manufacturing in 2025
- How PAT can enhance manufacturing, lower costs and optimise product quality
- Using spectroscopic tools, including NMR, to monitor critical quality attributes (CQA)
- The latest developments in PAT and its future potential in the pharmaceutical industry
Interested? Register your details to join us >>>
This webinar is sponsored by:
OUR SPEAKER
Yang Liu, Ph.D. – Senior Scientist II, Scientific Liaison in General Chapters USP
Dr Yang Liu is a Scientific Liaison for General Chapters at the United States Pharmacopeia (USP). Currently, Dr Liu is responsible for USP General Chapters development, including the spectroscopy technologies (such as UV, NIR, Raman, and NMR), process analytical technologies, and digital products. He previously served as the Manager of Product Quality and Analytical Methods in the Digital and Innovation division at USP. He has been a guest scientist at the National Institute of Standards and Technology (NIST) and an invited expert in the ISO Working Group (ISO/TC 34, WG 24). He graduated from the College of Pharmacy at the University of Illinois at Chicago.
FAQs
FAQs
Is the panel discussion free?
Yes – there is no charge to watch the panel discussion, either live or on-demand.
When will the panel discussion take place?
17 April at 3pm GMT.
Can I watch it later?
The panel discussion will become available to watch on-demand shortly after the live webinar takes place.
What are the benefits of attending live?
You’ll be able to ask the speakers your questions, which will be answered live in the Q&A towards the end of the session.
How long will the panel discussion be?
This panel discussion will last up to an hour.
What do I need to watch this panel discussion?
All you need is a computer with an internet connection. We recommend using headphones if possible if you’re in an office environment.
